Staar Surgical (STAA) Common Equity (2010 - 2026)

Staar Surgical (STAA) has reported Common Equity for 17 consecutive years, with $365.4 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Common Equity rose 8.56% year-over-year to $365.4 million; the trailing twelve-month figure through Jul 2026 stood at $365.4 million (up 8.56% YoY), and the FY2026 full-year result was $344.2 million, down 13.38% from the prior year.
• Common Equity climbed to $365.4 million in Q3 2026 per STAA's latest filing, from $352.4 million in the prior quarter.
• Across five years, Common Equity topped out at $428.1 million in Q3 2024 and bottomed at $276.3 million in Q2 2022.
• Historically, Common Equity has averaged $357.4 million across 5 years, with a median of $353.1 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Common Equity rose 29.72% in 2022, then fell 17.73% in 2025.
• Over 5 years, Common Equity stood at $336.1 million in 2022, then climbed by 14.83% to $386.0 million in 2023, then climbed by 2.95% to $397.3 million in 2024, then dropped by 10.96% to $353.8 million in 2025, then gained by 3.28% to $365.4 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $365.4 million, $352.4 million, and $344.2 million for Q3 2026, Q2 2026, and Q1 2026 respectively.